Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases

Marta Molero-Luis, Didac Casas-Alba, Gabriela Orellana, Aida Ormazabal, Cristina Sierra, Clara Oliva, Anna Valls, Jesus Velasco, Cristian Launes, Daniel Cuadras, Belén Pérez-Dueñas, Iolanda Jordan, Francisco J. Cambra, Juan D. Ortigoza-Escobar, Carmen Muñoz-Almagro, Angels Garcia-Cazorla, Thais Armangué, Rafael Artuch

Producció científica: Article en revista indexadaArticleAvaluat per experts

29 Cites (Scopus)


The elevation of neopterin in cerebrospinal fluid (CSF) has been reported in several neuroinflammatory disorders. However, it is not expected that neopterin alone can discriminate among different neuroinflammatory etiologies. We conducted an observational retrospective and case–control study to analyze the CSF biomarkers neopterin, total proteins, and leukocytes in a large cohort of pediatric patients with neuroinflammatory disorders. CSF samples from 277 subjects were included and classified into four groups: Viral meningoencephalitis, bacterial meningitis, acquired immune-mediated disorders, and patients with no-immune diseases (control group). CSF neopterin was analyzed with high-performance liquid chromatography. Microbiological diagnosis included bacterial CSF cultures and several specific real-time polymerase chain reactions. Molecular testing for multiple respiratory pathogens was also included. Antibodies against neuronal and glial proteins were tested. Canonical discriminant analysis of the three biomarkers was conducted to establish the best discriminant functions for the classification of the different clinical groups. Model validation was done by biomarker analyses in a new cohort of 95 pediatric patients. CSF neopterin displayed the highest values in the viral and bacterial infection groups. By applying canonical discriminant analysis, it was possible to classify the patients into the different groups. Validation analyses displayed good results for neuropediatric patients with no-immune diseases and for viral meningitis patients, followed by the other groups. This study provides initial evidence of a more efficient approach to promote the timely classification of patients with viral and bacterial infections and acquired autoimmune disorders. Through canonical equations, we have validated a new tool that aids in the early and differential diagnosis of these neuroinflammatory conditions.

Idioma originalAnglès
Número d’article18291
RevistaScientific Reports
Estat de la publicacióPublicada - 1 de des. 2020
Publicat externament


Navegar pels temes de recerca de 'Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases'. Junts formen un fingerprint únic.

Com citar-ho